Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?

Publication date

2018-02

Authors

Billiet, Thibo
Emsell, Louise
Vandenbulcke, Mathieu
Peeters, Ronald
Christiaens, Daan
Leemans, AlexanderORCID 0000-0002-9306-6126ISNI 0000000394149633
Van Hecke, Wim
Smeets, Ann
Amant, Frederic
Sunaert, Stefan

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

In a previous longitudinal diffusion tensor imaging (DTI) study, we observed cerebral white matter (WM) alterations (reduced fractional anisotropy (FA)) related to decreased cognitive performance 3–5 months after chemotherapy-treatment (t2) when compared to baseline (t1) (Deprez et al. in Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 30(3), 274–281. doi:10.1200/JCO.2011.36.8571, 2012). The current study investigates the evolution and the nature of these previously observed microstructural changes. Twenty-five young women with early-stage breast cancer who received chemotherapy treatment (C+), 14 who did not receive chemotherapy (C-) and 15 healthy controls (HC) previously studied, underwent reassessment 3–4 years after treatment (t3). We assessed (1) longitudinal changes of cognitive performance and FA and (2) cross-sectional group differences in myelin-water-imaging and multishell diffusion MRI metrics at t3. MRI metrics were assessed on a voxel-by-voxel basis and in regions-of-interest (ROI) in which previous WM injury was detected. Longitudinal results: Mixed-effects modeling revealed significant group-time interactions for verbal memory and processing speed (p <0.05) reflecting regained performance in the C+ group at t3. Furthermore, in chemotherapy-treated patients, FA returned to baseline levels at t3 in all ROIs (p <0.002), whereas no FA changes were seen in controls. Additionally, FA increase from t2 to t3 correlated with time since treatment in two of the four regions (r = 0.40, p <0.05). Cross-sectional results: Advanced diffusion MRI and myelin-water imaging metrics in the ROIs did not differ between groups. Similarly, no whole-brain voxelwise differences were detected. Initial WM alterations and reduced cognitive performance following chemotherapy-treatment were found to recover in a group of young breast cancer survivors three to four years after treatment.

Keywords

Breast cancer, Chemotherapy, Cognitive impairment, MR diffusion imaging, MR myelin water imaging, White matter, Taverne, Radiology Nuclear Medicine and imaging, Neurology, Clinical Neurology, Cognitive Neuroscience, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Behavioral Neuroscience, Journal Article

Citation

Billiet, T, Emsell, L, Vandenbulcke, M, Peeters, R, Christiaens, D, Leemans, A, van Hecke, W, Smeets, A, Amant, F, Sunaert, S & Deprez, S 2018, 'Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?', Brain Imaging and Behavior, vol. 12, no. 1, pp. 64-77. https://doi.org/10.1007/s11682-016-9665-8